I am one of the believers cyclosporin helps. In Canada we have:
* Restasis (0.05%)
* Teva-Cyclosporine (0.05%)
In the UK/EU/Japan we have:
* Ikervis (0.1%)
* Verkazia (0.1%)
Ikervis and Verkazia are the *same* formulation (and from the same company). One is indicated for adults (Ikervis) while the other for children (Verkazia).
Ikervis was DENIED by Health Canada in April 2018:
https://hpr-rps.hres.ca/reg-content/...inkID=RDS00379
but Verkazia was APPROVED by Health Canada, and is now moving towards being marketed, hopefully soon:
https://hpr-rps.hres.ca/reg-content/...inkID=RDS00501
I'm very excited to try Ikervis/Verkazia as I believe it has a better delivery vehicle compared to Restasis. Since Ikervis was denied but Verkazia approved, hopefully adults will still have access to Verkazia once it comes on the market.
* Restasis (0.05%)
* Teva-Cyclosporine (0.05%)
In the UK/EU/Japan we have:
* Ikervis (0.1%)
* Verkazia (0.1%)
Ikervis and Verkazia are the *same* formulation (and from the same company). One is indicated for adults (Ikervis) while the other for children (Verkazia).
Ikervis was DENIED by Health Canada in April 2018:
https://hpr-rps.hres.ca/reg-content/...inkID=RDS00379
but Verkazia was APPROVED by Health Canada, and is now moving towards being marketed, hopefully soon:
https://hpr-rps.hres.ca/reg-content/...inkID=RDS00501
I'm very excited to try Ikervis/Verkazia as I believe it has a better delivery vehicle compared to Restasis. Since Ikervis was denied but Verkazia approved, hopefully adults will still have access to Verkazia once it comes on the market.
Comment